positron emission tomography (PET) imaging
GPTKB entity
Statements (43)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical imaging technique
|
| gptkbp:abbreviation |
gptkb:PET
|
| gptkbp:combines |
gptkb:computed_tomography_(CT)
gptkb:magnetic_resonance_imaging_(MRI) anatomical imaging |
| gptkbp:coveredBy |
medical insurance (in some countries)
|
| gptkbp:detects |
gptkb:Alzheimer's_disease
gptkb:gamma_rays coronary artery disease tumors biochemical changes epileptic foci |
| gptkbp:developedBy |
1970s
|
| https://www.w3.org/2000/01/rdf-schema#label |
positron emission tomography (PET) imaging
|
| gptkbp:inventedBy |
gptkb:Edward_J._Hoffman
gptkb:Michael_E._Phelps |
| gptkbp:isGuidedBy |
nuclear medicine principles
|
| gptkbp:measures |
blood flow
glucose metabolism oxygen use tissue metabolism |
| gptkbp:noninvasive |
true
|
| gptkbp:practicedWorldwide |
true
|
| gptkbp:provides |
functional imaging
metabolic information |
| gptkbp:regulates |
gptkb:U.S._Food_and_Drug_Administration_(FDA)
|
| gptkbp:requires |
trained personnel
specialized equipment cyclotron-produced isotopes |
| gptkbp:riskFactor |
radiation exposure
|
| gptkbp:usedFor |
cancer diagnosis
cardiac imaging treatment planning neurological disorder assessment treatment monitoring |
| gptkbp:usedIn |
cardiology
neurology oncology |
| gptkbp:uses |
radioactive tracers
positron-emitting radionuclides |
| gptkbp:usesTracer |
gptkb:fluorodeoxyglucose_(FDG)
|
| gptkbp:bfsParent |
gptkb:Warburg_effect
|
| gptkbp:bfsLayer |
5
|